EP Wealth Advisors LLC Sells 957 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

EP Wealth Advisors LLC lowered its position in iShares Biotechnology ETF (NASDAQ:IBB) by 9.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,964 shares of the financial services provider’s stock after selling 957 shares during the quarter. EP Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,230,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Dorsey & Whitney Trust CO LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter worth about $206,000. Oppenheimer & Co. Inc. boosted its holdings in iShares Biotechnology ETF by 4.0% during the 4th quarter. Oppenheimer & Co. Inc. now owns 33,215 shares of the financial services provider’s stock valued at $4,512,000 after acquiring an additional 1,273 shares during the period. Gray Foundation bought a new position in iShares Biotechnology ETF in the 4th quarter valued at $17,890,000. XML Financial LLC increased its stake in iShares Biotechnology ETF by 9.2% in the fourth quarter. XML Financial LLC now owns 3,016 shares of the financial services provider’s stock worth $410,000 after purchasing an additional 255 shares during the period. Finally, Humankind Investments LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $611,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $144.77 on Wednesday. The firm has a fifty day moving average price of $145.68 and a 200-day moving average price of $138.97. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.